FindTrial
Sign In

Utvärdering av två oloika strategier att smärtbehandla patienter som genomgår ablationsbehandling mot hjärtrytmrubbningar i hjärtat

Utvärdering av två oloika strategier att smärtbehandla patienter som genomgår ablationsbehandling mot hjärtrytmrubbningar i hjärtat

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-004415-22-SE
Enrollment
Unknown
Registered
2006-09-25
Start date
2007-02-19
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing catheter ablation due to arrhythmias. MedDRA version: 8.1 Level: LLT Classification code 10016566 Term: Fibrillation atrial

Interventions

Product Name: morphine Pharmaceutical Form: Concentrate for solution for injection INN or Proposed INN: MORPHINE CAS Number: 57272 Concentration unit: mg/ml milligram(s)/millilitre Concentration type:

Sponsors

Karolinska University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing catheter ablation for atrial fibrillation or atrial fibrillation Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Patients unwilling to participate in the trial

Design outcomes

Primary

MeasureTime frame
Main Objective: To investigate if a strategy with premedication and iterated doses of analgesics and sedative compared with drugs on demand are preferred and better tolerated by patients undergoing catheter ablation.;Secondary Objective: ;Primary end point(s): Patients experienced pain.—

Countries

Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026